These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32866124)

  • 1. Screening for imprinting disorders in 58 patients with clinically diagnosed idiopathic short stature.
    Kawashima S; Yagi H; Hirano Y; Toki M; Izumi K; Dateki S; Namba N; Kamimaki T; Muroya K; Tanaka T; Fukami M; Kagami M;
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1335-1339. PubMed ID: 32866124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Imprinting Disorders in Short Children Born SGA and Silver-Russell Syndrome Spectrum.
    Fuke T; Nakamura A; Inoue T; Kawashima S; Hara KI; Matsubara K; Sano S; Yamazawa K; Fukami M; Ogata T; Kagami M
    J Clin Endocrinol Metab; 2021 Mar; 106(3):802-813. PubMed ID: 33236057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic Copy Number and Sequence Variants in Children Born SGA With Short Stature Without Imprinting Disorders.
    Hara-Isono K; Nakamura A; Fuke T; Inoue T; Kawashima S; Matsubara K; Sano S; Yamazawa K; Fukami M; Ogata T; Kagami M
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3121-e3133. PubMed ID: 35583390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients.
    Flechtner I; Lambot-Juhan K; Teissier R; Colmenares A; Baujat G; Beltrand J; Ajaltouni Z; Pauwels C; Pinto G; Samara-Boustani D; Simon A; Thalassinos C; Le Merrer M; Cormier-Daire V; Polak M
    Eur J Endocrinol; 2014 May; 170(5):677-84. PubMed ID: 24536087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-utero stress and mode of conception: impact on regulation of imprinted genes, fetal development and future health.
    Argyraki M; Damdimopoulou P; Chatzimeletiou K; Grimbizis GF; Tarlatzis BC; Syrrou M; Lambropoulos A
    Hum Reprod Update; 2019 Nov; 25(6):777-801. PubMed ID: 31633761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature.
    Hattori A; Katoh-Fukui Y; Nakamura A; Matsubara K; Kamimaki T; Tanaka H; Dateki S; Adachi M; Muroya K; Yoshida S; Ida S; Mitani M; Nagasaki K; Ogata T; Suzuki E; Hata K; Nakabayashi K; Matsubara Y; Narumi S; Tanaka T; Fukami M
    Endocr J; 2017 Oct; 64(10):947-954. PubMed ID: 28768959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders.
    Poole RL; Docherty LE; Al Sayegh A; Caliebe A; Turner C; Baple E; Wakeling E; Harrison L; Lehmann A; Temple IK; Mackay DJ;
    Am J Med Genet A; 2013 Sep; 161A(9):2174-82. PubMed ID: 23913548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.
    Syding LA; Nickl P; Kasparek P; Sedlacek R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of severe short stature below -3 SDS in a screened Finnish population.
    Kärkinen J; Miettinen PJ; Raivio T; Hero M
    Eur J Endocrinol; 2020 Nov; 183(5):481-488. PubMed ID: 33107436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth status of children and adolescents born small for gestational age at full term in Korea: data from the KNHANES-V.
    Kim JH; Kim DH; Lim JS
    J Pediatr Endocrinol Metab; 2020 May; 33(6):743-750. PubMed ID: 32447332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of ten candidate genes in a large multinational cohort of small for gestational age children and children with idiopathic short stature (NESTEGG study).
    de Graaff LC; Clark AJ; Tauber M; Ranke MB; Johnston LB; Caliebe J; Molinas C; Amin N; van Duijn C; Wollmann H; Wallaschofski H; Savage MO; Hokken-Koelega AC
    Horm Res Paediatr; 2013; 80(6):466-76. PubMed ID: 24280783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study.
    Fujita K; Nagasaka M; Iwatani S; Koda T; Kurokawa D; Yamana K; Nishida K; Taniguchi-Ikeda M; Uchino E; Shirai C; Iijima K; Morioka I
    Pediatr Int; 2016 May; 58(5):372-6. PubMed ID: 26617415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR; Shim YS; Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Polymorphisms Associated with Idiopathic Short Stature and First-Year Response to Growth Hormone Treatment.
    Quigley CA; Li YG; Brown MR; Pillai SG; Banerjee P; Scott RS; Blum WF; Parks JS
    Horm Res Paediatr; 2019; 91(3):164-174. PubMed ID: 30970347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature.
    Dias C; Giordano M; Frechette R; Bellone S; Polychronakos C; Legault L; Deal CL; Goodyer CG
    J Cell Mol Med; 2017 Nov; 21(11):2985-2999. PubMed ID: 28557176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA).
    Lazar L; Pollak U; Kalter-Leibovici O; Pertzelan A; Phillip M
    Eur J Endocrinol; 2003 Nov; 149(5):425-32. PubMed ID: 14585089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.